Schedule III

■ 𝗜𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻  On December 18 2025, President Donald Trump issued an executive order to promote research into medical marijuana and similar products, noting that such research is currently hampered by marijuana’s classification as a Schedule I drug under the Controlled Substances Act (CSA).  The order also directs relevant federal agencies Read more